Collectively, the assessment of PD‐L1, PD‐L2, and EGFR expression in naive tumor specimens does not accurately reflect the expression of these molecules at recurrence in patients with HNSCC. Here, PDCD1LG2 is linked to head and neck squamous cell carcinoma.